Corvus Pharmaceuticals, Inc. short interest in 2024
In 2024, Corvus Pharmaceuticals, Inc.'s disclosed short interest ran from 2.85% of shares outstanding on 12 Jan 2024 to 8.45% on 31 Dec 2024, a change of +5.60 percentage points. The year's high was 8.45% on 31 Dec 2024 and its low 2.18% on 15 Aug 2024, averaging 3.49% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.20 days on 30 Apr 2024. Full history: Corvus Pharmaceuticals, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 2.85% (12 Jan 2024)
- End of year
- 8.45% (31 Dec 2024)
- Change
- +5.60 pp
- High
- 8.45% (31 Dec 2024)
- Low
- 2.18% (15 Aug 2024)
- Average
- 3.49%
- Highest days to cover
- 13.20 (30 Apr 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 2.85% | 4.94 | |
| 31 Jan 2024 | 2.81% | 11.12 | |
| 15 Feb 2024 | 2.60% | 5.16 | |
| 29 Feb 2024 | 2.60% | 6.61 | |
| 15 Mar 2024 | 3.05% | 6.68 | |
| 28 Mar 2024 | 2.85% | 5.53 | 10-K filed, results (8-K) |
| 15 Apr 2024 | 2.78% | 7.52 | |
| 30 Apr 2024 | 2.77% | 13.20 | |
| 15 May 2024 | 2.62% | 2.50 | results (8-K), 10-Q filed |
| 31 May 2024 | 3.10% | 8.19 | |
| 14 Jun 2024 | 3.07% | 11.04 | |
| 28 Jun 2024 | 2.92% | 6.53 | |
| 15 Jul 2024 | 2.56% | 10.54 | |
| 31 Jul 2024 | 2.34% | 6.04 | |
| 15 Aug 2024 | 2.18% | 2.55 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 2.29% | 3.91 | |
| 13 Sep 2024 | 2.62% | 3.58 | |
| 30 Sep 2024 | 3.44% | 4.05 | |
| 15 Oct 2024 | 3.91% | 5.01 | |
| 31 Oct 2024 | 4.68% | 2.77 | |
| 15 Nov 2024 | 5.14% | 2.90 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 5.47% | 5.49 | |
| 13 Dec 2024 | 6.70% | 5.40 | |
| 31 Dec 2024 | 8.45% | 2.22 |
See also: Corvus Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.